ARCHIVES

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

This article is from The Cancer Letter archive.

Vol. 34 No. 2 | February 25, 2011

Download PDF Visit The Full Archive

Related Articles

Nobel Prize Recognizes Gene Targeting.

October 12, 2007

NCI Advisory Group, Other Cancer Meetings

July 25, 1986

FDA, ASCO Meet to Review Drug Approval Endpoints

April 25, 2003

NCI Told To “Cut Out The Nonsense,” Adequately Fund Programs At Centers Required By Mandates

November 5, 1976

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

April 8, 2005

Faulty Estimates Led NCI To Overstate Black-White Cancer Disparity In Atlanta

September 20, 2002